株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生細胞イメージングの世界市場の将来展望

Live Cell Imaging Market Outlook 2022

発行 RNCOS E-Services Pvt. Ltd. 商品コード 337543
出版日 ページ情報 英文 110 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
生細胞イメージングの世界市場の将来展望 Live Cell Imaging Market Outlook 2022
出版日: 2016年09月01日 ページ情報: 英文 110 Pages
概要

当レポートでは、世界の生細胞イメージング市場の現状と将来展望について分析し、技術の概要や利点・課題、現在の研究開発・普及状況、今後の市場成長の可能性・技術開発の方向性、主要企業のプロファイルなどについて調査・考察しております。

第1章 アナリストの見解

第2章 分析手法

第3章 生細胞イメージング:概略

第4章 生細胞イメージング市場の概要

第5章 市場のダイナミクス

  • 促進要因
  • 課題
  • 市場機会

第6章 世界の生細胞イメージング市場:製品別

  • 装置
  • 消耗品
  • ソフトウェア

第7章 世界の生細胞イメージング市場:用途別

  • 細胞生物学
  • 発生生物学
  • 幹細胞生物学
  • ドラッグデリバリ (薬剤送達)
  • その他の用途

第8章 世界の生細胞イメージング市場:技術別

  • 蛍光共鳴エネルギー移動 (FRET)
  • ハイコンテンツ解析 (HCA)
  • 蛍光 In Situ ハイブリダイゼーション (FISH)
  • その他の技術

第9章 世界の生細胞イメージング市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第10章 市場の傾向と発展

第11章 企業買収とその他の事業協力

第12章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Live Cell Imaging is defined as the study of living cells using high content screening or analysis systems and imaging systems such as microscopes, cell analyzers, etc. These technologies are used in number of investigations in order to provide critical insights into the fundamental nature of tissue and cellular function.

The new report introduced by RNCOS entitled "Live Cell Imaging Market Outlook 2022", includes a comprehensive analysis of the current and future outlooks of the Live Cell Imaging industry. The live cell imaging market is expected to reach US$ 7 Billion by 2022.

The report presents an in-depth analysis of several techniques used in imaging of live cells; as well as the segmentation of market by products, applications, technology and geography. Based on product types, the market has been segmented into equipments, consumables and softwares. Equipment market is expected to account for the largest share in 2016. According to technologies used in live cell imaging, the market has been divided into FRET, FISH, and other major techniques.

Similarly, geographical regions include North America, Europe, Asia Pacific and Rest of the World. North America is the largest market for live cell imaging due to high number of cell biology researches conducted in the region. As per RNCOS' analysis, live cell imaging is widely entering into a number of fields such as cell biology, developmental biology, drug discovery, stem cell biology, neurobiology and electrophysiology. It is emerging as a powerful tool for providing critical insights into cell function, including dynamic processes in living cells with nano-scale resolution in real time. Recent advances in microscopy techniques such as fluorescence light microscopy, including super resolution, photo activation, etc. and confocal microscopy are moving live cell imaging for a number of applications.

The last section of the report discusses about the prominent players in global live cell imaging market. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development and strength weakness analysis of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global live cell imaging market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Live Cell Imaging - An Introduction

4. Global Live Cell Imaging Market Overview

5. Market Dynamics

  • 5.1 Drivers
    • 5.1.1 Rising Incidences of Chronic Diseases
    • 5.1.2 Surging Demand for High-Content Screening Techniques
    • 5.1.3 Increasing Funding Support by Public and Private Sector
    • 5.1.4 Availability of Long-term Live Cell Imaging Platform
    • 5.1.5 Live Cell Imaging Instruments Accelerating Drug Discovery
  • 5.2 Challenges
    • 5.2.1 Maintaining Live Cells on Microscope Stage
    • 5.2.2 Mimicking the In Vivo Microenvironment
    • 5.2.3 Lack of Awareness
  • 5.3 Opportunities
    • 5.3.1 Adoption of High Content Screening Systems for Primary Screening
    • 5.3.2 Application of In Vivo Live Cell Imaging Techniques

6. Global Live Cell Imaging Market By Product

  • 6.1 Equipment
  • 6.2 Consumables
  • 6.3 Software

7. Global Live Cell Imaging Market by Application

  • 7.1 Cell Biology
  • 7.2 Developmental Biology
  • 7.3 Stem Cell Biology
  • 7.4 Drug Discovery
  • 7.5 Other Applications

8. Global Live Cell Imaging Market By Technology

  • 8.1 Fluorescent Resonance Energy Transfer (FRET)
  • 8.2 High Content Analysis (HCA)
  • 8.3 Fluorescence In Situ Hybridization (FISH)
  • 8.4 Other Technologies

9. Global Live Cell Imaging Market By Geography

  • 9.1 North America
  • 9.2 Europe
  • 9.3 Asia Pacific
  • 9.4 Rest of the World

10. Trends & Developments

  • 10.1 Fluorescent Probes Enriching Live Cell Imaging
  • 10.2 Introduction of LiveCyte Kinetic Cytometer for Label-free, Quantitative Phase Imaging
  • 10.3 Live Cell Imaging Revealing Intracellular Interactions
  • 10.4 Introduction of Single Plane Illumination Microscopy Advancing Live Cell Imaging

11. Mergers & Other Collaborations

12. Company Profiles

  • 12.1 Carl Zeiss GmbH
  • 12.2 Becton Dickenson & Co.
  • 12.3 Olympus Corporation
  • 12.4 ThermoFisher Scientific Inc.
  • 12.5 Merck KGaA
  • 12.6 Perkin Elmer, Inc.
  • 12.7 Nikon Instruments Inc.
  • 12.8 GE Healthcare
  • 12.9 Lonza
  • 12.10 Danaher Corporation

List of Figures:

  • Figure 4-1: Global - Live Cell Imaging Market (Billion US$), 2016-2022
  • Figure 6-1: Global - Live Cell Imaging Market by Products (%), 2016
  • Figure 6-3: Global - Live Cell Imaging Consumables Market (Billion US$), 2016 & 2022
  • Figure 6-4: Global - Live Cell Imaging Consumables Market by Type(%), 2016
  • Figure 6-5: Global - Live Cell Imaging Software Market (Billion US$), 2016 & 2022
  • Figure 7-1: Global - Live Cell Imaging Market by Applications (%), 2016
  • Figure 7-2: Global - Live Cell Imaging Market for Cell Biology (Billion US$), 2016 & 2022
  • Figure 7-3: Global - Live Cell Imaging Market for Developmental Biology (Billion US$), 2016 & 2022
  • Figure 7-4: Global - Live Cell Imaging Market for Stem Cell Biology (Billion US$), 2016 & 2022
  • Figure 7-5: Global - Live Cell Imaging Market for Drug Discovery (Billion US$), 2016 & 2022
  • Figure 7-6: Global - Live Cell Imaging Market for Other Applications (Billion US$), 2016 & 2022
  • Figure 8-1: Global - Live Cell Imaging Market by Technology (%), 2016
  • Figure 8-2: Global - Live Cell Imaging Market for Fluorescent Resonance Energy Transfer (Billion US$), 2016 & 2022
  • Figure 8-3: Global - Live Cell Imaging Market for High Content Analysis (Billion US$), 2016 & 2022
  • Figure 8-4: Global - Live Cell Imaging Market for Fluorescence In Situ Hybridization (Billion US$), 2016 & 2022
  • Figure 8-5: Global - Live Cell Imaging Market for Other Technologies (Billion US$), 2016 & 2022
  • Figure 9-1: Global - Live Cell Imaging Market by Geography (%), 2016
  • Figure 9-2: North America - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 9-3: Europe - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 9-4: Asia Pacific - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 9-5: Rest of the World - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 12-1: Carl Zeiss GmBH - Revenue Breakup by Business Segments (%), FY 2015
  • Figure 12-2: Carl Zeiss GmBH - Revenue Breakup by Geography (%), FY 2015
  • Figure 12-3: Becton Dickenson & Co. - Revenue Breakup by Business Segments (%), 2015
  • Figure 12-4: Becton Dickenson & Co. - Revenue Breakup by Geography (%), 2015
  • Figure 12-5: Olympus Corporation - Revenue Breakup by Business Segments (%), 2015
  • Figure 12-6: Olympus Corporation - Revenue Breakup by Geography (%), 2015
  • Figure 12-7: Olympus Corporation - Revenue Breakup of Scientific Solutions Business by Geography (%), 2015
  • Figure 12-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Business Segments (%), 2015
  • Figure 12-9: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2015
  • Figure 12-10: Merck KGaA - Breakup of Net Sales By Business Segments (%), 2015
  • Figure 12-11: Merck KGaA - Breakup of Net Sales By Geography (%), 2015
  • Figure 12-12: Perkin Elmer Inc. - Revenue Breakup by Business Segments (%), 2015
  • Figure 12-13: Perkin Elmer Inc. - Revenue Breakup by Geography (%), 2015
  • Figure 12-14: Nikon Instruments Inc. - Breakup of Net Sales by Business Segments (%), 2015
  • Figure 12-15: Nikon Instruments Inc. - Breakup of Net Sales by Geography (%), 2015
  • Figure 12-16: GE Healthcare - Revenue Breakup by Business Segments (%), 2015
  • Figure 12-17: GE Healthcare - Breakup of Revenue by Geographies (%), 2015
  • Figure 12-18: Lonza - Breakup of Sales by Business Segments (%), 2015
  • Figure 12-19: Danaher Corporation - Breakup of Sales by Business Segments (%), 2015
  • Figure 12-20: Danaher Corporation - Breakup of Sales by Geography (%), 2015

List of Tables:

  • Table 5-1: Global - Cancer Mortality Cases (Million), 2015 & 2020
  • Table 5-2: Funds Announced for Live Cell Imaging Research (2013-2015)
  • Table 9-1: North America - Elderly Population (Million), 2015 & 2030
  • Table 9-2: North America - Cancer Incidences (Million), 2015 & 2025
  • Table 9-3: Europe - Elderly Population (Million), 2015 & 2030
  • Table 9-4: Europe - Cancer Incidences (Million), 2015 & 2025
  • Table 9-5: Asia Pacific - Elderly Population (Million), 2015 & 2030
  • Table 9-6: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
  • Table 9-7: Latin America - Elderly Population (Million), 2015 & 2030
  • Table 9-8: Latin America - Cancer Incidences (Million), 2015 & 2025
  • Table 9-9: Africa - Elderly Population (Million), 2015 & 2030
  • Table 9-10: Africa - Cancer Incidences (Million), 2015 & 2025
  • Table 12-1: Carl Zeiss GmBH - Key Financials (Million US$), FY 2013-FY 2015
  • Table 12-2: Becton Dickenson & Co. - Key Financials(Million US$), 2013-2015
  • Table 12-3: Olympus Corporation - Key Financials (Million US$), 2013-2015
  • Table 12-4: ThermoFisher Scientific Inc.- Key Financials (Million US$), 2013-2015
  • Table 12-5: Merck KGaA - Key Financials (Million US$), 2013-2015
  • Table 12-6: Perkin Elmer Inc. - Key Financials (Million US$), 2013-2015
  • Table 12-7: Nikon Instruments Inc. - Key Financials (Million US$), 2013-2015
  • Table 12-8: GE Healthcare - Key Financials (Million US$), 2013-2015
  • Table 12-9: Lonza - Key Financials (Million US$), 2013-2015
  • Table 12-10: Danaher Corporation - Key Financials (Million US$), 2013-2015
Back to Top